Looking into the current session, Gentex Inc. (NASDAQ:GNTX) shares are trading at $23.70, after a 0.13% spike. Moreover, over the past month, the stock increased by 6.19%, but in the past year, decreased by 20.98%. Shareholders might be interested in…
iRobot Corporation (NASDAQ:IRBT) stock is getting hit on Monday after the company filed for Chapter 11 bankruptcy. iRobot stock is testing key support levels. Why did IRBT hit a new low? What To Know: The Massachusetts-based maker of the Roomba robotic…
It's that time again — investors are prepping for this week's earnings reports which include homebuilders, several apparel companies and a big tech company. MU stock is moving. See the chart and price action here. Monday, Dec. 15 The week…
Zillow Group Inc (NASDAQ:Z) (NASDAQ:ZG) shares are facing heavy selling pressure Monday amid reports that Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) is testing real estate listings in search results. Zillow Group stock is among today’s weakest performers. What’s behind Z decline? What To…
Bitcoin (CRYPTO: BTC) has been digesting the Trump-driven post-election surge, with price action at the end of 2025 showing correction and absorption rather than renewed upside momentum. Post-Election Rally Runs Into Heavy Supply The 80% surge following the 2024 presidential…
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Monday. Shares of Kyverna Therapeutics Inc (NASDAQ:KYTX) rose sharply during Monday's session after the company announced topline data from KYSA-8. The clinical-stage biopharmaceutical company shared topline…
Opendoor Technologies Inc (NASDAQ:OPEN) shares were trading higher in the pre-market session before pulling back and turning negative. The company announced an executive shakeup Monday morning. Here’s what you need to know. Opendoor Technologies stock is feeling bearish pressure. What’s behind…
Argenx SE (NASDAQ:ARGX) on Monday announced it would discontinue the Phase 3 UplighTED studies evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate to severe thyroid eye disease (TED). The decision is based on the recommendation from…
Argenx SE (NASDAQ:ARGX) on Monday announced it would discontinue the Phase 3 UplighTED studies evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate to severe thyroid eye disease (TED). The decision is based on the recommendation from…
Tesla Inc.'s (NASDAQ:TSLA) rally isn't just about EVs anymore — it's about who owns the future of robotics. As shares hover near 2025 highs, investors are increasingly treating autonomy, Optimus, and Robotaxi ambitions as core drivers of value rather than…